Click below to enter the website for patients in Britain who have been prescribed Nexviadyme, or their caregiver.
MAT-XU-2300562 (v4.0) Date of preparation: December 2023
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.
Adverse event reporting can be found at the bottom of the page.